BNTC
Benitec Biopharma Inc. (BNTC)
NASDAQ · Healthcare
Benitec Biopharma Inc. annual/quarterly shareholder equity history from 2019 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Benitec Biopharma Inc. shareholder equity for the quarter ending June 30, 2024 were 47.2M, a 23290.10% increase year-over-year.
- Benitec Biopharma Inc. shareholder equity for 2024 were 47.2M, a 23290.10% increase from 2023.
- Benitec Biopharma Inc. shareholder equity for 2023 were 202,000, a 92.99% decrease from 2022.
- Benitec Biopharma Inc. shareholder equity for 2022 were 2.9M, a 85.60% decrease from 2021.
- Benitec Biopharma Inc. shareholder equity for 2021 were 20.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Benitec Biopharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $47 |
| 2023 | $0 |
| 2022 | $3 |
| 2021 | $20 |
| 2020 | $10 |
| 2019 | $17 |
| Benitec Biopharma Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2024-06-30 | $47 |
| 2023-06-30 | $0 |
| 2022-06-30 | $3 |
| 2021-06-30 | $20 |
| 2020-06-30 | $10 |
| 2019-06-30 | $17 |
Benitec Biopharma Inc. Shareholder Equity — FAQ
Benitec Biopharma Inc. (BNTC) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNTC's shareholder equity history?
The chart and table above show Benitec Biopharma Inc.'s shareholder equity by year and by quarter, including the growth rate.